STOCK TITAN

Doximity Inc - DOCS STOCK NEWS

Welcome to our dedicated page for Doximity news (Ticker: DOCS), a resource for investors and traders seeking the latest updates and insights on Doximity stock.

Doximity Inc (DOCS) provides a HIPAA-secure digital platform connecting U.S. healthcare professionals through secure collaboration tools and medical networking features. This news hub offers investors and medical practitioners timely updates about platform developments, regulatory compliance milestones, and strategic partnerships.

Access comprehensive coverage of DOCS' operational updates including product innovations, financial results, and industry partnerships. All content is verified through primary sources to ensure accuracy for investment research and professional decision-making.

Key focus areas include updates on telehealth integrations, physician network expansion, and security protocol enhancements. Users benefit from centralized access to DOCS' regulatory filings, leadership announcements, and technology roadmap developments.

Bookmark this page for streamlined monitoring of Doximity's progress in advancing healthcare collaboration through its cloud-based platform. Check regularly for objective reporting on developments impacting both clinical workflows and long-term corporate strategy.

Rhea-AI Summary

Doximity (NYSE: DOCS) reported strong fiscal 2025 Q1 results, with total revenue up 17% year-over-year to $126.7 million. The company saw significant growth in profitability, with net income increasing 46% to $41.4 million and adjusted EBITDA rising 42% to $65.9 million. Doximity's CEO highlighted record engagement, with 590,000 unique providers using their AI, telehealth, messaging, and scheduling tools. The company's non-GAAP net income margin improved to 44.1% from 37.5% year-over-year. For Q2 FY2025, Doximity expects revenue between $126.5-$127.5 million and adjusted EBITDA of $62.5-$63.5 million. The full-year FY2025 guidance projects revenue of $514-$523 million and adjusted EBITDA of $248.5-$257.5 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
38.74%
Tags
-
Rhea-AI Summary

Doximity (NYSE:DOCS), the leading digital platform for U.S. medical professionals, has announced that it will release its fiscal 2025 first quarter financial results on August 8, 2024, after the market closes. The company will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the results. Interested parties can access the live audio webcast on Doximity's Investor Relations page at https://investors.doximity.com/ before the call. A replay of the webcast will be available on the website following the call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.28%
Tags
-
Rhea-AI Summary

Doximity, a leading digital platform for U.S. medical professionals, announced that CEO Jeff Tangney will present at the William Blair 44th Annual Growth Stock Conference. The presentation is scheduled for Wednesday, June 5, 2024, at 2:00 p.m. Central Time. This event provides Doximity an opportunity to showcase its growth strategies and business developments to potential investors and stakeholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.07%
Tags
conferences
Rhea-AI Summary

Doximity's 2024 Physician Compensation Report reveals a 5.9% increase in average physician compensation in 2023, following a 2.4% decline the previous year. The report highlights a 23% gender wage gap, with male physicians earning nearly $102,000 more than female physicians. Additionally, 81% of physicians feel overworked, with 59% considering employment changes, including early retirement. The physician shortage continues to impact 88% of respondents, with 86% expressing concern over the healthcare system’s ability to care for an aging population.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.21%
Tags
none
-
Rhea-AI Summary

Doximity (NYSE: DOCS) announced their Q4 and Fiscal Year 2024 financial results. For the fiscal year, total revenues reached $475.4 million, a 13% increase year-over-year, and net income grew by 31%. Q4 revenues were $118.1 million, showing a 6% increase. Adjusted EBITDA for the fiscal year rose by 25%, and net income margins improved from 26.9% to 31%. The company reported a diluted net income per share for the fiscal year of $0.72, up from $0.53. Doximity also introduced a $500 million stock repurchase program. The company's financial outlook for fiscal year 2025 includes revenues between $506 million and $518 million, and adjusted EBITDA between $238 million and $250 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.07%
Tags
-
Rhea-AI Summary
Doximity, Inc. (DOCS) will release its fiscal 2024 fourth quarter and full year results on May 16, 2024. The leading digital platform for U.S. medical professionals will discuss the financial results in a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET). Investors can listen to the live webcast on the Company's Investor Relations page.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.97%
Tags
Rhea-AI Summary
Doximity, Inc. (NYSE: DOCS) CFO Anna Bryson will participate in Raymond James Institutional Investor Conference and Barclays Global Healthcare Conference. Key details include dates, times, and speaker information.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.48%
Tags
conferences
-
Rhea-AI Summary
Doximity, Inc. (NYSE: DOCS) announced that its telehealth platform, Doximity Dialer, has been named 2024 Best in KLAS in the Telehealth - Video Conferencing Platforms segment for the third consecutive year. The platform received top ratings for culture, loyalty, operations, product, relationship, and value, based on direct feedback from healthcare professionals. Last quarter, over 400,000 unique providers used Doximity’s telehealth tools.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.24%
Tags
none
-
Rhea-AI Summary
Doximity, Inc. (DOCS) announces strong fiscal 2024 third quarter results, with total revenues of $135.3 million, up 17% year-over-year. The company also reported a net income margin of 35% and adjusted EBITDA margin of 54%, with net income growth of 43% and adjusted EBITDA growth of 32% year-over-year. Doximity's clinical workflow tools continue to drive daily use among doctors, and the company now counts 17 of the top 22 U.S. hospitals as enterprise software clients.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.24%
Tags
Rhea-AI Summary
Doximity, Inc. (DOCS) will report financial results for its fiscal third quarter ended December 31, 2023, after market close on February 8, 2024. The company will host a conference call and webcast to discuss the financial results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.56%
Tags
Doximity Inc

NYSE:DOCS

DOCS Rankings

DOCS Stock Data

9.98B
130.60M
2.15%
89.74%
2.67%
Health Information Services
Services-computer Programming Services
Link
United States
SAN FRANCISCO